Monitoring asparaginase activity to improve the management of patients with acute lymphoblastic leukemia: Experience in one center
Saved in:
Main Authors: | Marina García Morin (Author), Paula Melero Guardia (Author), Eduardo J. Bardón-Cancho (Author), Edgar Zapico Muñiz (Author), Elena Cela (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
by: Luke Maese, et al.
Published: (2022) -
Coagulation abnormality as a complication of L-asparaginase therapy in childhood lymphoblastic leukemia
by: Djajadiman Gatot, et al.
Published: (2016) -
Peg-asparaginase associated toxicities in children with acute lymphoblastic leukemia: A single-center cross-sectional study
by: Sameh Awwad, et al.
Published: (2024) -
Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance
by: Shih-Hsiang Chen
Published: (2015) -
Concurrent diabetic ketoacidosis and pancreatitis in Paediatric acute lymphoblastic leukemia receiving L-asparaginase
by: Patel Zeeshan Jameel, et al.
Published: (2020)